Atara Biotherapeutics Stock Discussion

$BIOSIG TECHNOLOGIES INC (BSGM.US)$ $Atara Biotherapeutics (ATRA.US)$ $SEALSQ Corp (LAES.US)$ $iHeartMedia (IHRT.US)$ $KORE Group (KORE.US)$ $Verb Technology (VERB.US)$ $MIND Technology (MIND.US)$ $SFIX (SFIX.CA)$ $VolitionRX (VNRX.US)$ $Anghami (ANGH.US)$ $Frequency Electronics (FEIM.US)$ $Bleichroeder Acquisition Corp. I (BACQ.US)$ $CleanCore Solutions (ZONE.US)$
📊⚡️📊

$Atara Biotherapeutics (ATRA.US)$
Updated Clinical Results: ALLELE study, a pivotal Phase 3 clinical trial evaluating tabelecleucel (tab-cel) in patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) after failure of rituximab or rituximab and chemotherapy.
The study demonstrated a statistically significant overall response rate (ORR) of 49%, with a median duration of response of 23 months ano nedian overall survival of 18.4 months. The sa...

$Scorpius Holdings (SCPX.US)$ $Perspective Therapeutics (CATX.US)$ $Turbo Energy (TURB.US)$ $Adverum Biotechnologies (ADVM.US)$ $NFT Ltd (MI.US)$ $Xylo Technologies (XYLO.US)$ $Lipocine (LPCN.US)$ $Massimo (MAMO.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Edesa Biotech (EDSA.US)$ $Atara Biotherapeutics (ATRA.US)$ $Eterna Therapeutics (ERNA.US)$ $DDC Enterprise (DDC.US)$
📊⚡️📊

$Atara Biotherapeutics (ATRA.US)$ Should have a re-entry at 7.70

$Atara Biotherapeutics (ATRA.US)$ over 30 million cash in the books acccording to there 30th of June Financial report , will have additional extra cash of 36 million on 5 September from institutional investors and big pharma company by issuing them around 4 million shares at 8.25 $ , will further receive 20 million + 60 Million by Pierre Fabre Pharmaceuticals once FDA approves there EBV drug in Jan 2025 .
Should see increased acitivity soon as all these large investors have interest in this comp...

$Atara Biotherapeutics (ATRA.US)$
good buy

$Atara Biotherapeutics (ATRA.US)$ Atara Biotherapeutics Announces $36 Million Registered Direct Offering